|Trade Name||COHERENT PDL1 AND PDL2 LAMBDA PLUS PHOTODYNAMIC LASERS|
|Applicant||COHERENT MEDICAL GROUP|
||General & Plastic Surgery
|Supplement Type||normal 180 day track|
|Supplement Reason|| labeling change - indications|
|Expedited Review Granted?|| No|
|Approval Order Statement |
Approval for the additional indication for use for the reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nonsmall cell lung cancer (nsclc).